This study is in progress, not accepting new patients
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Peter Stock
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Peter Stock
Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants. He is co-director of the Pancreatic Islet Cell Transplantation Program. In his research, Stock studies body mechanisms that lead to transplant rejection when the donor and recipient are not genetically identical.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Johns Hopkins University
- ID
- NCT03500315
- Study Type
- Interventional
- Participants
- Expecting 160 study participants
- Last Updated